INTRODUCTION
Actinomycetes produce a number of secondary metabolites, including antibiotics and phytotoxins. Antibiotic production by Actinomycetes is closely related to such morphological differentiation as aerial mycelium formation and sporulation. l) Thus the regulation of aerial mycelium formation may increase the yield of antibiotic production and reduce the damage caused by plant pathogenic Actinomycetes.
Pamamycin-607, an aerial mycelium-inducing substance isolated from Streptomyces alboniger IFO12738, is a sixteen-membered macrodiolide with a dimethylamino group-bearing side chain. 2)3> We isolated 14 pamamycin homologues with different alkyl substituents at R1-R5, determined their structures, and found that change from CH3 to CH2CH3 at R3 or R4 caused loss of aerial mycelium-inducing activity. 4)5> We also showed that the dimethylamino group is indispensable for the activity because the chemically prepared desdimethylamino derivative of pamamycin-607 completely lacked activity6) and that the L-character conformation of pamamycin-607 is necessary for activity by comparing the activities and the conformations of the ring-opened derivative and its two constituent hydroxy acids. 6)
The EtOAc extract of S. alboniger produced a new Dragendorff)s reagent-positive spot with a smaller R f value than pamamycin on silica gel TLC. Three new compounds were isolated using a combination of ODS and NH2 HPLCs.
MS spectroscopy showed that their structures were de-N-methylpamamycins ( Fig. 1 ) with the aid of labeled compounds prepared in a methioninemethyl-d3 feeding culture of S. alboniger. 7) We describe here the isolation of de-N-methylpamamycin-579, 593A and 593B and aerial mycelium-inducing and growth inhibition activities of de-N-methylpamamycin-579 and 593A in comparison with those of pamamycin-593 and 607. Clarification of the detailed structures of de-N-methylpamamycin-593A and 593B was reported elsewhere. 7> MATERIALS AND METHODS
Fermentation
S. alboniger IFO 12738 was cultured as previously reported5) to produce new pamamycin derivatives. De-N-methylpamamycin-579 
Isolation
The procedure used to produce the new pamamycin derivatives is shown in Figs. 2 and 3. Diaion CHP-20 resin was added to the culture broth, then the resin and mycelia were collected by filtration. The resin-mycelia mixture was macerated in acetone, and the extract evaporated to an aqueous residue, which then was treated with EtOAc after being adjusted to pH 8. The EtOAc extract was partially concentrated, mixed with n-hexane and diisopropylamine then passed through a short silica gel column. The passed and washed fractions were combined, concentrated and again purified in a silica gel column. The new derivatives were flushed from the column with the solvent system EtOAc-n-hexane-diisopropylamine 5: 5: 0. 5 after the elution of pamamycins with the same solvent system (2: 8: 0. 5) (Fig. 2) . Three compounds were isolated by Develosil ODS-5 and NH2-5 HPLCs (Fig. 3 ).
Feeding Experiment with Methionine-methyl-d3
The seed culture was grown by transferring a loopful of S. alboniger IFO 12738 from an agar slant to a 500-ml shaking flask containing 100 ml of medium. 5) The inoculated flask was oscillated on a reciprocal shaker (150 rpm) for 3 days at 28C, after which 3 ml portions of the broth were used to inoculate other shaking flasks each containing 100 ml of the same medium supplemented with methionine-methyl-d3 (Sigma-Aldrich Japan K. K. ) (1 mg/ml), prior to sterilization. Fermentation was carried out for 6 days under conditions similar to those used for the seed culture. The culture broth was treated as shown in Fig. 2. 
Bioassay for Aerial Mycelium-inducing and Growth
Inhibition A ctivities Aerial mycelium-inducing activity was assayed by the paper disc method with S. alboniger IFO 12738 on Hickey and Tresner)s agar medium containing cerulenin (Sigma-Aldrich Japan K. K. ). 6> An ethanol solution of cerulenin (600 jig in 100 )cl EtOH) was spread on the medium (10 ml) in a plate (9 cm diameter), and the plate left overnight to vaporize the EtOH. A sample solution was infused to a paper disc (8mm diameter) and, after the solvent had evaporated, the disc placed on the inoculated plate. After 5 days of incubation at 28C, the diameter of the aerial mycelium-inducing zone was measured.
Growth inhibition activity was assayed by a procedure similar to that used for aerial mycelium-inducing activity, except that cerulenin treatment was omitted and the sample dose was higher.
RESULTS

Isolation
The first isolation step was improved by the addition of Diaion CHP-20 resin and collection of the resin and mycelia by filtration. Purification of the fraction containing the new derivatives by Develosil ODS-5 HPLC gave three peaks (Fig. 3a) . El-MS analysis showed that the new derivatives were eluted in the order of MW, as in the case of pamamycins. 4) Fractions containing the MW 579 and 593 derivatives were chromatographed on Develosil NH2-5 HPLC. The MW 579 fraction gave a single peak I (2. 45 mg) (Fig. 3b) and the MW 593 one gave 3 peaks; peaks II (2. 87 mg), III (2. 55 mg) and IV (2. 38 mg) (Fig. 3c ).
Mass Spectral Analysis of Methionine-methyl-d3
Labeled Compounds The mass spectrum of pamamycin-607 (Fig. 4a) showed characteristic fragment ions at m/z 564 (M+-43) and m/z 100 derived from a-cleavage of the dimethylamino group. New compound IV (MW 593) had an M+-43 ion at m/z 550, whereas the other fragment ion appeared at m/z 86, 14 mass units smaller than that of pamamycin (Fig. 4b) . These results indicate that the new derivatives are de-N-methyl derivatives of pamamycins.
To verify this, the incorporation of methionine-methyld3 into pamamycins and the new compounds was examined. Pamamycin-607 obtained from the feeding experiment had an intense fragment ion at m/z 106 together with weak ions at m/z 100 and 103 (Fig. 4c) . The methyl-d3-labeled derivative of IV had an isotope peak at m/z 89 but none at m/z 92 (Fig. 4d) . These findings confirm that the methyl groups on the dimethylamino group are derived from methionine and that the new compound is a de-N-methyl derivative of pamamycin.
The alkyl substituents R1-R5 of IV were identified as 2 by capillary GC-MS analysis (DB-l, 0. 25mm X 15 m, 0. 1 j m film thickness, J & W Scientific) of their respective diol products obtained by LiA1H4 degradation. 4)5) IV was named de-N-methylpamamycin-593A (Fig. 1) . Similarly, the structures of I and III were found to be 1 and 3, and the compounds named de-N-methylpamamycin-579 and de-N-methylpamamycin-593B. The alkyl substituent arrangements of de-N-methylpamamycin-593A (2) and de-N-methylpamamycin-579 (1) respectively were identical to those of pamamycin-607 (5) and pamamycin-593 (4). Peak II was a mixture of two isomers with different small hydroxy acid moieties. The stereochemistries of the new derivatives should be the same as those of the pamamycins, because the small diol fragments from 1, 2 and 3 were identical to that obtained from pamamycin-607 by capillary GC-MS analysis.
Aerial Mycelium-inducing Activity
Aerial mycelium-inducing activity was assayed by the paper disc method with the pamamycin producer S. alboniger IFO 12738 on medium containing cerulenin, 8) a polyketide biosynthesis inhibitor. The structure of the smaller hydroxy acid moiety of pamamycin is similar to that of nonactic acid, the constituent hydroxy acid of the macrotetrolide antibiotic nonactin. Nonactic acid is biosynthesized from acetyl-, propinonyl-and susccinylCoA via the polyketide pathway. 9) We speculated that pamamycin also is biosynthesized via the polyketide pathway.
Cerulenin at 40, ug/ml partially inhibited aerial mycelia formation and at 60, ug/ml completely inhibited it, whereas it did not inhibit substrate mycelia growth. TLC analysis showed that pamamycin production with Cerulenin decreased compared to that in medium without cerulenin (data not shown).
The aerial mycelium-inducing activities of the de-Nmethylpamamycins were compared with those of pamamycins with the same alkyl substituent arrangement. Pamamycin-607 required 4. 2, ug/disc to produce an aerial mycelium-induction zone with a diameter of 4 cm, whereas de-N-methylpamamycin-593A had similar activity at 2. 9, ug/disc, indicating that N-demethylation produced a 1. 4-fold increase in activity. Similarly, N-demethylation from pamamycin-593 to de-Nmethylpamamycin-579 gave a 1. 5-fold increase in activity (Fig. Sa) .
Growth Inhibition Activity
Pamamycin-607 shows growth inhibition activity at a dose about 10-fold more that was required for aerial mycelium induction. Growth inhibition activities of the new compounds and those of the pamamycins were compared at the dose that produced a growth inhibition zone with a diameter of 2 cm. N-Demethylation decreased inhibition about 0. 6-fold (from pamamycin-607 to de-N-methylpamamycin-593A) and 0. 9-fold (from pamamycin-593 to de-N-methylpamamycin-579) (Fig.  Sb) , the opposite of its effect on aerial myceliuminduction. DISCUSSION N-Demethylation caused an increase in aerial mycelium-inducing activity and a decrease in growth inhibition activity. This supports our idea4) that the aerial mycelium-inducing and growth inhibition activities are produced by different mechanisms.
Structural change from the dimethylamino to monomethylamino group causes a decrease in steric hindrance around the nitrogen atom, increasing its polarity and nucleophilicity. To characterize the physicochemical property that directs the aerial myceliuminducing and growth inhibition activities of pamamycin, we are preparing various new derivatives by chemical modification of pamamycins and de-N-methylpamamycins.
Development of a new pamamycin derivative that has aerial mycelium-inducing but no growth inhibition activity should provide a useful tool with which to clarify the 
